The bill mandates that the Under Secretary of Commerce for Industry and Security place the Ministry of Public Security’s Institute of Forensic Science of China on the Department of Commerce’s Entity List within 60 days of enactment, and it names two institutional aliases. It also creates a limited presidential waiver: the President, through the Commerce Secretary, can prevent the listing if he certifies to two congressional committees within the same 60‑day window that the Institute is not acting contrary to U.S. foreign policy and is not implicated in abuses in Xinjiang.
This is a narrow, targeted intervention: rather than asking BIS to review the Institute under its usual administrative processes, Congress would impose a statutory designation with an explicit timeline and a specific, time-limited waiver route. For exporters, universities, and agencies that work with Chinese forensic or identification technology, the bill would immediately change licensing expectations and due-diligence requirements and establishes a congressional test for avoiding the listing rather than leaving the matter to agency discretion.
At a Glance
What It Does
The bill requires the BIS Under Secretary to add the Ministry of Public Security’s Institute of Forensic Science of China to the Commerce Department’s Entity List within 60 days, listing two named aliases. It permits the President, via the Commerce Secretary, to waive the requirement if he submits a certification to two congressional committees within the same 60-day period that the Institute is not implicated in Xinjiang abuses and is not acting against U.S. foreign policy.
Who It Affects
U.S. exporters and manufacturers of dual‑use forensic, identification, and surveillance technologies; research institutions and law‑enforcement bodies that share forensic expertise or equipment; the Institute itself and related Chinese entities; and the Bureau of Industry and Security (BIS), which must implement the listing.
Why It Matters
The measure converts a policy decision about a single Chinese forensic body into a statutory directive, changing how export controls are applied and limiting administrative discretion. That move can harden U.S. policy toward entities linked to Xinjiang abuses and sets a precedent for Congress to impose entity-listing mandates in other cases.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The bill is short and procedural: it names the Ministry of Public Security’s Institute of Forensic Science of China and orders the Commerce Department’s Bureau of Industry and Security to place that institute on the Export Administration Regulations’ Entity List within 60 days. The text explicitly includes two alternate names for the same institute to make the listing broad enough to capture how the entity might be referenced in transactions or documents.
Once on the Entity List, the listed institute would be subject to the export‑control regime that BIS administers: U.S. exports, reexports, and certain transfers of items subject to the EAR to the institute typically require a license and are subject to a presumption of denial for many controlled items. The bill does not itself define licensing policy or particular licensing exceptions; it relies on the existing mechanics and authorities of the EAR and BIS enforcement.The only path the statute provides to avoid the mandated listing is a presidential waiver.
That waiver requires the President, acting through the Commerce Secretary, to send a certification to the Senate Commerce Committee and the House Energy and Commerce Committee — within the same 60‑day period — that the institute is neither acting contrary to U.S. foreign policy nor implicated in or contributing to the specific pattern of repression, mass arbitrary detention, forced labor, and high‑technology surveillance identified in Xinjiang. If that certification is submitted, the Commerce Department may decline to place the institute on the Entity List.
The bill also defines “entity list” by reference to Supplement No. 4 to part 744 of the EAR (or successor regulations), anchoring the statutory action in the existing regulatory framework.
The Five Things You Need to Know
The bill requires BIS to add the Institute of Forensic Science of the Ministry of Public Security (including two named aliases) to the Entity List within 60 days of enactment.
The two aliases named are the Forensic Identification Center of the Ministry of Public Security of the PRC and the Material Identification Center of the Ministry of Public Security of the PRC.
The President can block the listing only by submitting, within the same 60 days, a certification to the Senate Commerce Committee and the House Energy and Commerce Committee that the institute is not acting contrary to U.S. foreign policy and is not implicated in Xinjiang abuses.
The statute anchors the action to the existing Entity List in Supplement No. 4 to part 744 of the Export Administration Regulations (or successor regulations), so existing licensing and enforcement mechanics apply.
The bill does not create new criminal penalties, licensing rules, or delisting procedures — it triggers the standard export‑control consequences that follow an Entity List entry.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Short title
Provides the Act’s name: the 'Confronting CCP Human Rights Abusers Act.' This is purely nominal but signals congressional intent and frames the measure as targeted at human‑rights accountability tied to the People’s Republic of China.
Mandatory Entity-List Inclusion and Aliases
Directs the Under Secretary of Commerce for Industry and Security to include the Ministry of Public Security’s Institute of Forensic Science of China on the Entity List within 60 days and specifies two alternate institutional names. Naming aliases is a practical drafting choice to reduce the risk that transactions route around the listing by using variant names, and it forces BIS to update Supplement No. 4 to part 744 accordingly.
Presidential Waiver and Certification Requirement
Creates a limited waiver: the President, through the Commerce Secretary, may waive the requirement to list if, within 60 days, he certifies to the Senate Commerce Committee and the House Energy and Commerce Committee that the institute is not acting against U.S. foreign policy and is not implicated in Xinjiang abuses. The provision ties the waiver to a specific evidentiary certification to Congress and imposes a strict timing constraint; it does not prescribe standards for evidence or create an administrative review process beyond the certification.
Definition of Entity List
Defines 'entity list' by reference to the Commerce Department’s existing regulatory instrument — Supplement No. 4 to part 744 of the EAR (or successor regulations). That cross‑reference means implementation uses the established licensing procedures, licensing policy (including presumption of denial where applicable), and enforcement authorities that already govern listed entities.
This bill is one of many.
Codify tracks hundreds of bills on Foreign Affairs across all five countries.
Explore Foreign Affairs in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Uyghur, Kazakh, and other Xinjiang human‑rights advocates — a statutory listing signals U.S. accountability and provides a concrete leverage point to restrict access to U.S. forensic and identification technologies alleged to support repression.
- Congressional oversight actors and sanctions advocates — the bill gives Congress a direct mechanism to compel export‑control action and a clear benchmark for evaluating executive compliance with human‑rights policy.
- Competitor suppliers outside the listed entity's network — U.S. firms that refuse to engage with implicated Chinese bodies may gain clearer market rules and reputational protection when trading partners or customers demand compliance with human‑rights‑focused export controls.
Who Bears the Cost
- The Ministry of Public Security’s Institute of Forensic Science (and any entities captured by the aliases) — the listing will restrict their access to U.S.-origin items, software, and technology and make procurement more difficult.
- U.S. exporters of forensic, biometric, or related dual‑use technologies — they will face new license requirements, heightened due‑diligence burdens, and a higher risk of license denial for transactions involving the listed institute.
- Academic researchers and public‑sector forensic labs that collaborate with Chinese counterparts — the listing could chill exchanges, joint projects, and evidence‑sharing arrangements that rely on tools or data subject to the EAR.
- Bureau of Industry and Security and Commerce Department — they must process the mandated listing quickly, update regulatory text, handle increased licensing workload, and respond to compliance questions without an agency‑initiated review period.
Key Issues
The Core Tension
The bill trades administrative discretion and a deliberative agency process for a rapid, congressionalized tool to hold a Chinese forensic body accountable for alleged Xinjiang abuses — forcing a choice between immediate, targeted action to signal accountability and the risks that a blunt statutory listing could undercut lawful international forensic cooperation, complicate export‑control enforcement, and limit an agency’s ability to tailor licensing decisions based on nuanced evidence.
The bill substitutes a statutory command for a discretionary administrative designation. That approach speeds action but reduces administrative fact‑finding: BIS would implement the listing on a tight timetable rather than completing a full internal investigation or a notice‑and‑comment rulemaking.
The waiver route is narrow and time‑bound — it requires a presidential certification to two named congressional committees within 60 days — which could politicize evidentiary judgments and make routine interagency deliberation difficult.
Operationally, an Entity List entry imposes licensing requirements and a presumption of denial for many controlled exports, but it is not an absolute export ban and will not automatically cut off non‑EAR items or locally sourced supplies. Firms may reroute procurement to non‑U.S. suppliers, diminishing U.S. leverage.
The bill also leaves open how BIS should treat affiliates not named in the text, how to handle classified or law‑enforcement exceptions in practice, and how future delisting or review would occur beyond the single presidential certification window.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.